Orca-T significantly improved survival free of moderate-to-severe cGvHD compared to alloHSCT, with rates of 78% versus 38%. Orca-T demonstrated a lower incidence of severe acute GvHD and non-relapse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback